Peter Mac researchers have found a way to predict which patients with locally advanced rectal cancers might be diverted into a “watch and wait” group, potentially avoiding the need for lower bowel removal surgery and its life-long consequences.
An experimental drug developed by Peter Mac’s Professor Joe Trapani could help prevent deaths from one of the world’s most common viral infections, hepatitis B.
Today we recognised the generosity of the Australian Cancer Research Foundation (ACRF) for their $2m research grant which has provided researchers from Peter Mac and our VCCC partners with cutting edge tech which will help them break new ground in cancer research.
New research into the link between obesity and liver cancer, led by Peter Mac and Monash University, has indicated patients won't always develop serious liver diseases as a precursor to cancer.
Peter Mac’s Professor John Seymour and Professor Andrew Roberts, from the Walter and Eliza Hall Institute of Medical Research, have jointly received the 2018 Victoria Prize for Life Sciences.
Congratulations to Professor Mark Dawson who was today announced as a recipient of Cancer Council Victoria's Sir Edward Dunlop Research Fellowship. The Fellowship provides $1.55M over five years to support Prof Dawson's pioneering research into epigenetic regulators, unlocking their potential to support new cancer treatments.
An innovative new model of heightened care for patients, who are identified as being at medium risk of post-operative complications, is underway at Peter Mac.
Congratulations to Peter Mac medical oncologist Professor Kelly-Anne Phillips who has been elected as a Fellow of the Australian Academy of Health and Medical Sciences (AAHMS).